These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25697919)

  • 1. Soluble ST2--analytical considerations.
    Mueller T; Jaffe AS
    Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble ST2 in heart failure.
    Dieplinger B; Mueller T
    Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of sST2 in cardiac diseases.
    Pascual-Figal DA; Lax A; Perez-Martinez MT; del Carmen Asensio-Lopez M; Sanchez-Mas J;
    Clin Chem Lab Med; 2016 Jan; 54(1):29-35. PubMed ID: 26544104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.
    Mueller T; Dieplinger B
    Expert Rev Mol Diagn; 2013 Jan; 13(1):13-30. PubMed ID: 23256700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.
    Januzzi JL; Mebazaa A; Di Somma S
    Am J Cardiol; 2015 Apr; 115(7 Suppl):26B-31B. PubMed ID: 25665762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2: a novel biomarker for heart failure.
    Bhardwaj A; Januzzi JL
    Expert Rev Mol Diagn; 2010 May; 10(4):459-64. PubMed ID: 20465500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble ST2: A complex and diverse role in several diseases.
    Homsak E; Gruson D
    Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology of ST2: the International ST2 Consensus Panel.
    Pascual-Figal DA; Januzzi JL
    Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
    Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
    Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST2 as a cardiovascular risk biomarker: from the bench to the bedside.
    Januzzi JL
    J Cardiovasc Transl Res; 2013 Aug; 6(4):493-500. PubMed ID: 23558647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
    Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
    J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
    Miller AM; Liew FY
    Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of soluble ST2 levels in serum of HTLV-1 infected individuals.
    Zahedi Avval F; Shomali S; Nadri M; Boostani R; Jarahi L; Youssefi M
    Acta Microbiol Immunol Hung; 2015 Jun; 62(2):137-45. PubMed ID: 26132834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.
    Willems S; Hoefer I; Pasterkamp G
    Minerva Med; 2012 Dec; 103(6):513-24. PubMed ID: 23229370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel.
    Januzzi JL; Pascual-Figal D; Daniels LB
    Am J Cardiol; 2015 Apr; 115(7 Suppl):70B-5B. PubMed ID: 25670638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
    Zhang K; Zhang XC; Mi YH; Liu J
    Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST2 and IL-33 in pregnancy and pre-eclampsia.
    Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
    PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay.
    Dieplinger B; Januzzi JL; Steinmair M; Gabriel C; Poelz W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Nov; 409(1-2):33-40. PubMed ID: 19699192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.